Sharp share Price drop today.
AGM said there were $200 million in projects in the pipeline, but did not say how that was defined. It must involve projects we are hoping for, but may or may not get.
We were told two thirds of revenue prediction of $27-30 million would be in second half. In response to question how much of the second half was definite Rob said around half. That suggests we will do $10 million in first half and that around $10 million of the second half is firm. Problem is we have no clarity as to what they are.
Most companies getting contracts announce their order book or work in hand, as well as tenders. This provides a tguide to definite and potential work and its status. While PET provides a forecast we have no clarity on definite work ahead. This is partly a problem of working in China where orders seem to be vague.
Until we get clarity on coming work the share price may remain under pressure.
- Forums
- ASX - By Stock
- PET
- Ann: AGM Presentation
Ann: AGM Presentation, page-13
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PET (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online